[HTML][HTML] DNA damage response signaling pathways and targets for radiotherapy sensitization in cancer
RX Huang, PK Zhou - Signal transduction and targeted therapy, 2020 - nature.com
Radiotherapy is one of the most common countermeasures for treating a wide range of
tumors. However, the radioresistance of cancer cells is still a major limitation for …
tumors. However, the radioresistance of cancer cells is still a major limitation for …
DNA damage response signaling pathways and targets for radiotherapy sensitization in cancer
RX Huang, PK Zhou - Signal Transduction and Targeted Therapy, 2020 - cir.nii.ac.jp
抄録< jats: title> Abstract</jats: title>< jats: p> Radiotherapy is one of the most common
countermeasures for treating a wide range of tumors. However, the radioresistance of …
countermeasures for treating a wide range of tumors. However, the radioresistance of …
DNA damage response signaling pathways and targets for radiotherapy sensitization in cancer.
RX Huang, PK Zhou - Signal Transduction & Targeted …, 2020 - search.ebscohost.com
Radiotherapy is one of the most common countermeasures for treating a wide range of
tumors. However, the radioresistance of cancer cells is still a major limitation for …
tumors. However, the radioresistance of cancer cells is still a major limitation for …
[HTML][HTML] DNA damage response signaling pathways and targets for radiotherapy sensitization in cancer
RX Huang, PK Zhou - Signal Transduction and Targeted Therapy, 2020 - ncbi.nlm.nih.gov
Radiotherapy is one of the most common countermeasures for treating a wide range of
tumors. However, the radioresistance of cancer cells is still a major limitation for …
tumors. However, the radioresistance of cancer cells is still a major limitation for …
DNA damage response signaling pathways and targets for radiotherapy sensitization in cancer.
RX Huang, PK Zhou - Signal Transduction and Targeted Therapy, 2020 - europepmc.org
Radiotherapy is one of the most common countermeasures for treating a wide range of
tumors. However, the radioresistance of cancer cells is still a major limitation for …
tumors. However, the radioresistance of cancer cells is still a major limitation for …
DNA damage response signaling pathways and targets for radiotherapy sensitization in cancer
RX Huang, PK Zhou - Signal transduction and targeted …, 2020 - pubmed.ncbi.nlm.nih.gov
Radiotherapy is one of the most common countermeasures for treating a wide range of
tumors. However, the radioresistance of cancer cells is still a major limitation for …
tumors. However, the radioresistance of cancer cells is still a major limitation for …
[PDF][PDF] DNA damage response signaling pathways and targets for radiotherapy sensitization in cancer
2020 - pathologyinnovationcc.org
The increasing prevalence of cancer worldwide is a major challenge to the improvement of
quality and length of life. According to reports, 975,396 patients were newly diagnosed with …
quality and length of life. According to reports, 975,396 patients were newly diagnosed with …
DNA damage response signaling pathways and targets for radiotherapy sensitization in cancer
RXZ Huang - 2020 - hero.epa.gov
Radiotherapy is one of the most common countermeasures for treating a wide range of
tumors. However, the radioresistance of cancer cells is still a major limitation for …
tumors. However, the radioresistance of cancer cells is still a major limitation for …
DNA damage response signaling pathways and targets for radiotherapy sensitization in cancer
H Rui-Xue, Z Ping-Kun - Signal Transduction and Targeted …, 2020 - search.proquest.com
Radiotherapy is one of the most common countermeasures for treating a wide range of
tumors. However, the radioresistance of cancer cells is still a major limitation for …
tumors. However, the radioresistance of cancer cells is still a major limitation for …